在抗生素耐药性研究中，对照组的选择是一个重要但被忽视的问题。 - Suppr

Suppr

超能文献

Control group selection is an important but neglected issue in studies of antibiotic resistance.

作者信息

Harris A D, Samore M H, Carmeli Y

出版信息

Ann Intern Med. 2000 Jul 18;133(2):159. doi: 10.7326/0003-4819-133-2-200007180-00018.

DOI:10.7326/0003-4819-133-2-200007180-00018

PMID:10896645

Abstract

摘要

相似文献

Control group selection is an important but neglected issue in studies of antibiotic resistance.

Ann Intern Med. 2000 Jul 18;133(2):159. doi: 10.7326/0003-4819-133-2-200007180-00018.

Control group selection is an important but neglected issue in studies of antibiotic resistance.

Ann Intern Med. 2000 Jun 6;132(11):925. doi: 10.7326/0003-4819-132-11-200006060-00024.

Perspectives towards antibiotic resistance: from molecules to population.

J Microbiol. 2019 Mar;57(3):181-184. doi: 10.1007/s12275-019-0718-8.

Science academies of G7 nations call for action on antibiotic resistance and neglected tropical diseases.

BMJ. 2015 Apr 30;350:h2346. doi: 10.1136/bmj.h2346.

Pervasive selection for and against antibiotic resistance in inhomogeneous multistress environments.

Nat Commun. 2016 Jan 20;7:10333. doi: 10.1038/ncomms10333.

Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group.

Microb Drug Resist. 2010 Dec;16(4):303-8. doi: 10.1089/mdr.2009.0134. Epub 2010 Jun 7.

Protocol: a 'One health' two year follow-up, mixed methods study on antibiotic resistance, focusing children under 5 and their environment in rural India.

BMC Public Health. 2015 Dec 30;15:1321. doi: 10.1186/s12889-015-2632-2.

[Antibiotic use: excesses and consequences].

Rev Prat. 2003 Sep 30;53(14):1527-32.

Surveillance programmes and antibiotic resistance: worldwide and regional monitoring of antibiotic resistance trends.

Handb Exp Pharmacol. 2012(211):31-43. doi: 10.1007/978-3-642-28951-4_3.

Antibiotic clinical trials revisited.

J Antimicrob Chemother. 2000 Nov;46(5):651-2. doi: 10.1093/jac/46.5.651.

引用本文的文献

From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Antibiotics (Basel). 2022 Feb 4;11(2):201. doi: 10.3390/antibiotics11020201.

The Clinical and Molecular Epidemiology of Noncarbapenemase-Producing Carbapenem-Resistant : A Case-Case-Control Matched Analysis.

Open Forum Infect Dis. 2020 Jul 17;7(8):ofaa299. doi: 10.1093/ofid/ofaa299. eCollection 2020 Aug.

Methods and issues in studies of CRE.

Virulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28.

Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.

Yonsei Med J. 2014 Mar;55(2):467-75. doi: 10.3349/ymj.2014.55.2.467.

Outcome of ICU patients with Clostridium difficile infection.

Crit Care. 2012 Nov 5;16(6):R215. doi: 10.1186/cc11852.

Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Antimicrob Agents Chemother. 2010 May;54(5):2010-6. doi: 10.1128/AAC.01131-09. Epub 2010 Mar 8.

Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.

Antimicrob Agents Chemother. 2008 Apr;52(4):1413-8. doi: 10.1128/AAC.01103-07. Epub 2008 Jan 28.

The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.

Antimicrob Agents Chemother. 2004 Jun;48(6):1934-40. doi: 10.1128/AAC.48.6.1934-1940.2004.

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

Emerg Infect Dis. 2003 Nov;9(11):1415-22. doi: 10.3201/eid0911.030284.

Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Antimicrob Agents Chemother. 2003 Sep;47(9):2882-7. doi: 10.1128/AAC.47.9.2882-2887.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Control group selection is an important but neglected issue in studies of antibiotic resistance.

作者信息

Harris A D, Samore M H, Carmeli Y

出版信息

Ann Intern Med. 2000 Jul 18;133(2):159. doi: 10.7326/0003-4819-133-2-200007180-00018.

DOI:10.7326/0003-4819-133-2-200007180-00018

PMID:10896645

Abstract

摘要

相似文献

Control group selection is an important but neglected issue in studies of antibiotic resistance.

Ann Intern Med. 2000 Jul 18;133(2):159. doi: 10.7326/0003-4819-133-2-200007180-00018.

Control group selection is an important but neglected issue in studies of antibiotic resistance.

Ann Intern Med. 2000 Jun 6;132(11):925. doi: 10.7326/0003-4819-132-11-200006060-00024.

Perspectives towards antibiotic resistance: from molecules to population.

J Microbiol. 2019 Mar;57(3):181-184. doi: 10.1007/s12275-019-0718-8.

Science academies of G7 nations call for action on antibiotic resistance and neglected tropical diseases.

BMJ. 2015 Apr 30;350:h2346. doi: 10.1136/bmj.h2346.

Pervasive selection for and against antibiotic resistance in inhomogeneous multistress environments.

Nat Commun. 2016 Jan 20;7:10333. doi: 10.1038/ncomms10333.

Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group.

Microb Drug Resist. 2010 Dec;16(4):303-8. doi: 10.1089/mdr.2009.0134. Epub 2010 Jun 7.

Protocol: a 'One health' two year follow-up, mixed methods study on antibiotic resistance, focusing children under 5 and their environment in rural India.

BMC Public Health. 2015 Dec 30;15:1321. doi: 10.1186/s12889-015-2632-2.

[Antibiotic use: excesses and consequences].

Rev Prat. 2003 Sep 30;53(14):1527-32.

Surveillance programmes and antibiotic resistance: worldwide and regional monitoring of antibiotic resistance trends.

Handb Exp Pharmacol. 2012(211):31-43. doi: 10.1007/978-3-642-28951-4_3.

Antibiotic clinical trials revisited.

J Antimicrob Chemother. 2000 Nov;46(5):651-2. doi: 10.1093/jac/46.5.651.

引用本文的文献

From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Antibiotics (Basel). 2022 Feb 4;11(2):201. doi: 10.3390/antibiotics11020201.

The Clinical and Molecular Epidemiology of Noncarbapenemase-Producing Carbapenem-Resistant : A Case-Case-Control Matched Analysis.

Open Forum Infect Dis. 2020 Jul 17;7(8):ofaa299. doi: 10.1093/ofid/ofaa299. eCollection 2020 Aug.

Methods and issues in studies of CRE.

Virulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28.

Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.

Yonsei Med J. 2014 Mar;55(2):467-75. doi: 10.3349/ymj.2014.55.2.467.

Outcome of ICU patients with Clostridium difficile infection.

Crit Care. 2012 Nov 5;16(6):R215. doi: 10.1186/cc11852.

Antimicrob Agents Chemother. 2010 May;54(5):2010-6. doi: 10.1128/AAC.01131-09. Epub 2010 Mar 8.

Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.

Antimicrob Agents Chemother. 2008 Apr;52(4):1413-8. doi: 10.1128/AAC.01103-07. Epub 2008 Jan 28.

The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.

Antimicrob Agents Chemother. 2004 Jun;48(6):1934-40. doi: 10.1128/AAC.48.6.1934-1940.2004.

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.

Emerg Infect Dis. 2003 Nov;9(11):1415-22. doi: 10.3201/eid0911.030284.

Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Antimicrob Agents Chemother. 2003 Sep;47(9):2882-7. doi: 10.1128/AAC.47.9.2882-2887.2003.